Clinical Trial Update: ExoLuminate Study for Early Detection of Pancreatic Cancer

View source ↗

Summary

The ExoLuminate Study, sponsored by Biological Dynamics, is currently recruiting to evaluate exosome-based biomarkers for the early detection of pancreatic canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Biological Dynamics | Conditions: Pancreas Cancer, Exosomes | Status: RECRUITING